Boris Kalandar
Managing Director, Co-Founder @ MentorTech Ventures
Boris Kalandar is a Series B investor at MentorTech Ventures focused on Medical and Health Care. Mr. Kalandar is a co-founder of MentorTech and has 20 years experience in business development, venture capital, M&A, and management consulting. Prior to becoming a full time venture capitalist, he co-founded 3 successful technology companies. He has also completed a number of acquisitions, management turnarounds and exits. He presentlyrepresents MentorTech on the Board of Directors of Molecular Detection, Inc., EyeIC and NeuroDiagnostic Devices. He is also a Board member of Rainbow Medical, Ltd. (Israel).He is also the founder of SVM Advisors, LLC, a 20 year old boutique technology merchant bank. SVM has raised over $100 million for portfolio companies and other venture funds. Mr. Kalandar is also a former senior executive with SMG, Inc, which was named three times to “Inc. 500” fastest growing companies list. He led the $50 million private equity re-capitalization exit for the company. He started his venture capital investment experience at Safeguard Scientifics (NYSE: SFE), a public venture capital holding company, where he was with the first early stage venture capital fund sponsored by Safeguard.For the last 13 years, he has served on the Investment Advisory Committee of Ben Franklin Technology Partners of Southeast Pennsylvania.Mr. Kalandar received his MBA in Finance and Strategic Planning from the Wharton School, and his MSEE from the Institute of Electrical Engineering in St. Petersburg, Russia
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Boris Kalandar invests in
Stages Boris Kalandar invests in
Countries Boris Kalandar invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Health Diagnostics 1 (50%)
Stage
- Series B 1 (50%)
- Funding Round 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Molecular Detection
|
Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of "sample-to-answer" Detect-Readyâ„¢ molecular diagnostic tests for the rapid detection of infectious diseases. The company is preparing to launch its first product, the Detect-Ready assay for the rapid detection of methicillin-resistant Staphylococcus aureus(MRSA), a growing problem among hospitals and other health facilities around the globe. | $1.9M / Series B / Apr 16, 2012 | |
|
Molecular Detection
|
Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of "sample-to-answer" Detect-Readyâ„¢ molecular diagnostic tests for the rapid detection of infectious diseases. The company is preparing to launch its first product, the Detect-Ready assay for the rapid detection of methicillin-resistant Staphylococcus aureus(MRSA), a growing problem among hospitals and other health facilities around the globe. | $4.7M / Dec 01, 2009 |
Co-Investors
Robin Hood Ventures
2 deals together
Elm Spring
1 deal together
Mid-Atlantic Angel Group
1 deal together
About MentorTech Ventures
MentorTech Ventures is a seed- and early-stage venture capital fund that invests in companies from the University of Pennsylvania ecosystem. These companies typically have key founders or managers who are students, faculty members or alumni of the university. Sometimes, the companies are based on intellectual property that originated at Penn.
MentorTech Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Boris Kalandar
Managing Director, Co-Founder
|
|||
Brett Topche
Managing Director
|
|||
Michael Aronson
Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Boris Kalandar invest in?
Boris Kalandar invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Boris Kalandar?
Public channels for Boris Kalandar include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Boris Kalandar last invest?
The most recent investment recorded for Boris Kalandar closed in Apr 2012. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
